ABBV vs ETN: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Eaton Corporation plc — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-24.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Eaton Corporation plc · Industrials
$438.76
+32.2% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
ETN has more upside to fair value
(+32.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
ETN |
| Current Price |
$261.70 |
$438.76 |
| Fair Value Estimate |
$259.04 |
$579.99 |
| Upside to Fair Value |
-1.0%
|
+32.2%
|
| Market Cap |
$462.4B |
$170.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
29.6x
|
| Price / Sales |
7.2x
|
5.7x
|
| Price / FCF |
23.6x
|
37.9x
|
| Revenue Growth YoY |
+10.2%
|
+21.4%
|
| Gross Margin |
71.5%
|
35.9%
|
| Operating Margin |
29.3%
|
17.7%
|
| Return on Equity |
-136.5%
|
19.6%
|
| Dividend Yield |
2.61% |
0.99% |
| FCF Yield |
4.25%
|
2.64%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Eaton Corporation plc is a Dublin-headquartered power management company with roughly 97,303 employees, operating electrical, aerospace, vehicle and eMobility segments that supply power distribution, circuit protection, power quality and reliability equipment and services. The business quality is high: TTM gross margin of 35.9%, TTM operating margin of 17.7%, TTM net margin of 12.8% and ROE of 19…
Accumulation Zones
| Metric |
ABBV |
ETN |
| Zone Low |
$194.28 |
$434.99 |
| Zone High |
$220.18 |
$492.99 |
| In Buy Zone? |
No
|
Yes
|